Last updated on December 2018

Dementia-related Hallucinations and / or Delusions

Brief description of study

Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis


Detailed Study Description

The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia.

Clinical Study Identifier: TX217807

Find a site near you

Start Over

Clinical Research Professionals, LLC

17998 Chesterfield Airport Rd., Suite 100 Chesterfield, MO United States
  Connect »